Cigna Group (CI) Expected to Announce Quarterly Earnings on Thursday

Cigna Group (NYSE:CI) is projected to announce its Q2 2026 results before the market opens on Thursday, July 30th. Analysts expect the company to announce earnings of $7.60 per share and revenue of $70.1399 billion for the quarter. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Individuals are encouraged to explore the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, July 30, 2026 at 8:30 AM ET.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. The firm had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.74 EPS. On average, analysts expect Cigna Group to post $30 EPS for the current fiscal year and $33 EPS for the next fiscal year.

Cigna Group Stock Performance

Shares of CI stock opened at $285.29 on Thursday. The firm has a market cap of $75.47 billion, a price-to-earnings ratio of 12.09, a PEG ratio of 1.12 and a beta of 0.29. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The company’s 50 day moving average is $286.11 and its 200 day moving average is $280.66.

Insider Buying and Selling at Cigna Group

In related news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This represents a 85.46% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.60% of the stock is owned by insiders.

Institutional Trading of Cigna Group

A number of institutional investors have recently bought and sold shares of the stock. Wilkerson Advisory Group LLC purchased a new stake in Cigna Group during the 4th quarter worth approximately $25,000. Prosperity Bancshares Inc acquired a new stake in shares of Cigna Group during the fourth quarter worth $29,000. Kemnay Advisory Services Inc. acquired a new stake in shares of Cigna Group during the fourth quarter worth $29,000. Measured Wealth Private Client Group LLC purchased a new stake in shares of Cigna Group during the third quarter valued at $56,000. Finally, Johnson Financial Group Inc. grew its holdings in shares of Cigna Group by 445.9% during the third quarter. Johnson Financial Group Inc. now owns 202 shares of the health services provider’s stock valued at $58,000 after buying an additional 165 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the company. Royal Bank Of Canada lifted their price target on Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a report on Friday, May 1st. Jefferies Financial Group decreased their price objective on Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a research note on Monday, April 20th. Robert W. Baird set a $337.00 price objective on Cigna Group in a research report on Friday, May 1st. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, June 20th. Finally, Wells Fargo & Company boosted their target price on shares of Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and an average price target of $338.80.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.